Shasqi presented five posters at the 2024 American Association for Cancer Research (AACR) Annual Meeting in San Diego, California on April 10, 2024.

View the abstracts below:

Nectin-4 targeted therapy with MMAE protodrug results in anti-tumor efficacy mediated by click chemistry

Tumor targeted activation of an attenuated exatecan protodrug through Click Chemistry demonstrates efficacy in murine tumor studies

A click chemistry-based HER2 targeting agent activates a decoupled MMAE payload making it highly differentiated in efficacy and safety than ADCs

Improving anti-tumor efficacy by modulating a separate HER2 activator and an MMAE payload and reuniting both through click chemistry

Click chemistry enabled selective activation of highly cytotoxic MMAE payload at tumors using TROP2 targeting agent